Investigational Site Number :1240008
Hamilton, Ontario L8L 3C3
0 studies enrolling now · 1 studies all time
What they study most
Atopic Dermatitis
Studies at this site
Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis
— Completed